Strides Pharma Science Limited

Strides Pharma Science Limitedverified

STAR.NS

Price:

$880.65

Market Cap:

$81.17B

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2002-06-26

Stock Exchange

NSE

Ticker

STAR.NS

The Enterprise Value as of December 2025 (TTM) for Strides Pharma Science Limited (STAR.NS) is 98.18B

According to Strides Pharma Science Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 98.18B. This represents a change of 24.64% compared to the average of 78.77B of the last 4 quarters.

Strides Pharma Science Limited (STAR.NS) Historical Enterprise Value (quarterly & annually)

How has STAR.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Strides Pharma Science Limited over the last ten years is 56.84B. The current 98.18B Enterprise Value has changed 17.17% with respect to the historical average. Over the past ten years (40 quarters), STAR.NS's Enterprise Value was at its highest in in the September 2025 quarter at 92.65B. The Enterprise Value was at its lowest in in the June 2022 quarter at 16.13B.

Quarterly (TTM)
Annual

Average

56.84B

Median

54.41B

Minimum

34.37B

Maximum

78.78B

Strides Pharma Science Limited (STAR.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Strides Pharma Science Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 70.36%

Maximum Annual Enterprise Value = 78.78B

Minimum Annual Increase = -35.80%

Minimum Annual Enterprise Value = 34.37B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202578.78B34.34%
202458.65B47.94%
202339.64B-8.81%
202243.47B-25.76%
202158.56B70.36%
202034.37B-30.01%
201949.11B-2.30%
201850.26B-35.80%
201778.29B1.36%
201677.24B40.38%

Strides Pharma Science Limited (STAR.NS) Average Enterprise Value

How has STAR.NS Enterprise Value performed in the past?

The current Enterprise Value of Strides Pharma Science Limited (STAR.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

59.02B

5-year avg

55.82B

10-year avg

56.84B

Strides Pharma Science Limited (STAR.NS) Enterprise Value vs. Peers

How is STAR.NS’s Enterprise Value compared to its peers?

Strides Pharma Science Limited’s Enterprise Value is greater than Aarti Pharmalabs Limited (65.41B), greater than Aarti Pharmalabs Limited (65.41B), greater than FDC Limited (67.26B), greater than FDC Limited (67.26B), greater than Marksans Pharma Limited (81.87B), greater than Marksans Pharma Limited (81.87B), greater than Procter & Gamble Health Limited (92.03B), greater than Procter & Gamble Health Limited (92.03B), greater than Shilpa Medicare Limited (64.86B), greater than Sanofi India Limited (96.99B),

Build a custom stock screener for Strides Pharma Science Limited (STAR.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Strides Pharma Science Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Strides Pharma Science Limited (STAR.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Strides Pharma Science Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Strides Pharma Science Limited's Enterprise Value?

What is the highest Enterprise Value for Strides Pharma Science Limited (STAR.NS)?

What is the 3-year average Enterprise Value for Strides Pharma Science Limited (STAR.NS)?

What is the 5-year average Enterprise Value for Strides Pharma Science Limited (STAR.NS)?

How does the current Enterprise Value for Strides Pharma Science Limited (STAR.NS) compare to its historical average?